Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

The Diverse Phenotypic and Mutational Landscape Induced by Fluoroquinolone Treatment

ABSTRACT: The Diverse Phenotypic and Mutational Landscape Induced by Fluoroquinolone Treatment

PROVIDER: PRJEB83321 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR14051027.fastq.gz	Fastqsanger.gz
	ERR14051028.fastq.gz	Fastqsanger.gz
	ERR14051029.fastq.gz	Fastqsanger.gz
	ERR14051030.fastq.gz	Fastqsanger.gz
	ERR14051031.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 9

Similar Datasets

The Diverse Phenotypic and Mutational Landscape Induced by Fluoroquinolone Treatment

Project description:We conducted whole genome sequencing on eight evolved E. coli strains (S1–S8) and the parental wild-type (WT) strain to identify mutations arising from ofloxacin treatments. These strains (S1-S8), generated through fluoroquinolone-mediated adaptive laboratory evolution (ALE), exhibited varying levels of tolerance and resistance. The ALE experiment involved intermittent antibiotic treatments of eight independent cultures over 22 days. The untreated WT strain served as a baseline to pinpoint mutations in the evolved strains.

2024-12-23 | E-MTAB-14682 | biostudies-arrayexpress

Relapsed Acute Lymphoblastic Leukemia (ALL): Mutational Landscape

Project description:Relapsed Acute Lymphoblastic Leukemia (ALL): Mutational Landscape

| PRJNA597498 | ENA

Relapsed Acute Lymphoblastic Leukemia (ALL): Mutational Landscape

Project description:Relapsed Acute Lymphoblastic Leukemia (ALL): Mutational Landscape

| PRJNA597499 | ENA

Individualized proteogenomics reveals mutational landscape of melanoma patients in response to immunotherapy

Project description:Immune checkpoint inhibitors are used to restore or augment antitumor immune response and show great promise in treatment of melanoma and other types of cancers. However, only a relatively small percentage of patients are fully responsive to immune checkpoint inhibition, mostly due to tumor heterogeneity and primary resistance to therapy. Both of these features are largely driven by accumulation of patient-specific mutations, pointing to the need for personalized approaches in diagnostics and immunotherapy. Proteogenomics integrates patient-specific genomic and proteomic data to study cancer development and resistance mechanisms, as well as tumor heterogeneity in individual patients. Here, we use a proteogenomic approach to characterize the mutational landscape of samples derived from four clinical melanoma patients at the genomic, proteomic and phosphoproteomic level. Integration of datasets enabled identification and quantification of an extensive number of sample-specific amino acid variants, among them many were not previously reported in melanoma. We detected a disproportional number of alternate peptides between treated and untreated (naïve) samples with a high potential to influence signal transduction. This is one of the first proteogenomic study designed to study the mutational landscape of patient-derived melanoma tissue samples in response to immunotherapy.

2022-02-16 | PXD028700 | Pride

The mutational landscape of a Prion-like domain

Project description:The mutational landscape of a Prion-like domain

| PRJNA526635 | ENA

Mutational Landscape of Lethal Castrate Resistant Prostate Cancer

Project description:Mutational Landscape of Lethal Castrate Resistant Prostate Cancer

| PRJNA177193 | ENA

Genome Sequencing of Gastric Cancer Reveals Diverse Mutational and Pathogen Signatures

Project description:We leveraged massively parallel sequencing approach to comprehensively characterize the spectrum of somatic mutations and genomic rearrangements in two intestinal-type gastric adenocarcinomas from patients with and without active Helicobacter pylori infections. The tumours exhibited distinct patterns of genomic changes with more than 16,000 somatic substitutions on average, focal amplifications and rearrangements in the non-active infected tumour and a 7-fold enrichment of micro-deletions in the infected tumour. Paired-end sequences from large insert libraries revealed the structure and origins of large amplicons, including one involving the oncogene KRAS. The mutational frequencies of the tumours revealed patterns of H. pylori infection and mutagenesis and a unique exome signature, providing insights into mechanisms that define the mutational landscape of gastric cancer. For the tumour with active infection, we also reconstructed the genome of the pathogenic H. pylori strain from the raw sequence reads, demonstrating the power of whole-genome shotgun sequencing for simultaneously characterizing the tumour and its associated carcinogen genome.

2012-12-05 | GSE30833 | GEO

The mutational landscape of cancer’s vulnerability to ionizing radiation

Project description:The mutational landscape of cancer’s vulnerability to ionizing radiation

| PRJNA895034 | ENA

A deep mutational scanning platform to characterize the fitness landscape of anti-CRISPR proteins

Project description:Deep mutational scanning is a powerful method for exploring the mutational fitness landscape of proteins. Its adaptation to anti-CRISPR proteins, which are natural CRISPR-Cas inhibitors and key players in the co-evolution of microbes and phages, facilitates their characterization and optimization. Here, we developed a robust anti-CRISPR deep mutational scanning pipeline in Escherichia coli that combines synthetic gene circuits based on CRISPR interference with flow cytometry coupled sequencing and mathematical modeling. Using this pipeline, we characterized comprehensive single point mutation libraries for AcrIIA4 and AcrIIA5, two potent inhibitors of CRISPR-Cas9. The resulting mutational fitness landscapes revealed considerable mutational tolerance for both Acrs, suggesting an intrinsic redundancy with respect to Cas9 inhibitory features, and – for AcrIIA5 – indicated mutations that boost Cas9 inhibition. Subsequent in vitro characterization suggested that the observed differences in inhibitory potency between mutant inhibitors were mostly due to changes in binding affinity rather than protein expression levels. Finally, to demonstrate that our pipeline can inform Acrs-based genome editing applications, we employed a selected subset of mutant inhibitors to increase CRISPR-Cas9 target specificity by modulating Cas9 activity. Taken together, our work establishes deep mutational scanning as a powerful method for anti-CRISPR protein characterization and optimization.

2024-03-01 | GSE254101 | GEO

Somatic Mutational Landscape of Wild Populus trichocarpa tree [ncRNA-seq]

Project description:Somatic Mutational Landscape of Wild Populus trichocarpa tree [ncRNA-seq]

| PRJNA549498 | ENA